Back
Amicus Therapeutics Stock Predictions
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
25
FOLD
Amicus Therapeutics
Last Price:
$5.73
Seasonality Move:
20.05%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.Amicus Therapeutics Stock Forecast
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23.2% based on the past 17 years of stock performance.
-
Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
-
Is Amicus Therapeutics Stock Undervalued?The current Amicus Therapeutics [FOLD] share price is $5.73. The Score for FOLD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23.2% based on the past 17 years of stock performance.
Amicus Therapeutics Stock Rating
Sell
25
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics overpriced?
-
Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
Amicus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
12.65
52-Week Low:
5.72
Prediction Charts
Market Cap:
1.8B
Price in USD:
5.73
Volume:
5.4M
Beta:
0.98
Technical Analysis
SMA50:
6.43
SMA100:
7.76
SMA200:
9.10
52-Wk Change:
-41.35%
Stock Predictions
-
Is Amicus Therapeutics stock public?Yes, Amicus Therapeutics is a publicly traded company.
-
What is the Amicus Therapeutics stock quote today?The Amicus Therapeutics stock price is 5.73 USD today.
-
How to buy Amicus Therapeutics stock online?You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-30 | 6.18 | 6.07 | 6.20 | 6.03 |
| Jun-2 | 6.09 | 6.16 | 6.20 | 6.06 |
| Jun-3 | 6.15 | 6.26 | 6.36 | 6.11 |
| Jun-4 | 6.24 | 6.10 | 6.32 | 6.09 |
| Jun-5 | 6.10 | 5.96 | 6.12 | 5.90 |
| Jun-6 | 6.03 | 6.16 | 6.19 | 6.00 |
| Jun-9 | 6.19 | 6.03 | 6.20 | 6.02 |
| Jun-10 | 6.09 | 6.11 | 6.22 | 6.05 |
| Jun-11 | 6.17 | 6.14 | 6.23 | 6.09 |
| Jun-12 | 6.13 | 6.17 | 6.19 | 6.00 |
| Jun-13 | 6.05 | 6.03 | 6.22 | 6.01 |
| Jun-16 | 6.07 | 6.05 | 6.15 | 5.89 |
| Jun-17 | 5.99 | 5.80 | 5.99 | 5.78 |
| Jun-18 | 5.78 | 5.73 | 5.88 | 5.72 |
Amicus Therapeutics Earnings
Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics Forecast Revenue Growth
Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.09 per share, and an increase next year of $0.35 per share.
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.